147 related articles for article (PubMed ID: 15358586)
1. Sphingolipids in the chemoprevention of colon cancer.
Schmelz EM
Front Biosci; 2004 Sep; 9():2632-9. PubMed ID: 15358586
[TBL] [Abstract][Full Text] [Related]
2. Suppression of breast xenograft growth and progression in nude mice: implications for the use of orally administered sphingolipids as chemopreventive agents against breast cancer.
Simon KW; Tait L; Miller F; Cao C; Davy KP; LeRoith T; Schmelz EM
Food Funct; 2010 Oct; 1(1):90-8. PubMed ID: 21776459
[TBL] [Abstract][Full Text] [Related]
3. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
[TBL] [Abstract][Full Text] [Related]
4. Regulation of beta-catenin and connexin-43 expression: targets for sphingolipids in colon cancer prevention.
Simon KW; Roberts PC; Vespremi MJ; Manchen S; Schmelz EM
Mol Nutr Food Res; 2009 Mar; 53(3):332-40. PubMed ID: 18837472
[TBL] [Abstract][Full Text] [Related]
5. Structure elucidation and chemical profile of sphingolipids in wheat bran and their cytotoxic effects against human colon cancer cells.
Zhu Y; Soroka DN; Sang S
J Agric Food Chem; 2013 Jan; 61(4):866-74. PubMed ID: 23286461
[TBL] [Abstract][Full Text] [Related]
6. Ceramide-beta-D-glucuronide: synthesis, digestion, and suppression of early markers of colon carcinogenesis.
Schmelz EM; Bushnev AS; Dillehay DL; Sullards MC; Liotta DC; Merrill AH
Cancer Res; 1999 Nov; 59(22):5768-72. PubMed ID: 10582697
[TBL] [Abstract][Full Text] [Related]
7. Ceramides and ceramide metabolites in cell regulation: evidence for dietary sphingolipids as inhibitors of colon carcinogenesis.
Schmelz EM; Merrill AH
Nutrition; 1998 Sep; 14(9):717-9. PubMed ID: 9760598
[No Abstract] [Full Text] [Related]
8. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling.
Wu K; Yang Q; Mu Y; Zhou L; Liu Y; Zhou Q; He B
Int J Oncol; 2012 Jul; 41(1):292-8. PubMed ID: 22469784
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
10. Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.
Wu X; Song M; Qiu P; Rakariyatham K; Li F; Gao Z; Cai X; Wang M; Xu F; Zheng J; Xiao H
Carcinogenesis; 2017 Apr; 38(4):455-464. PubMed ID: 28207072
[TBL] [Abstract][Full Text] [Related]
11. Natural sphingadienes inhibit Akt-dependent signaling and prevent intestinal tumorigenesis.
Fyrst H; Oskouian B; Bandhuvula P; Gong Y; Byun HS; Bittman R; Lee AR; Saba JD
Cancer Res; 2009 Dec; 69(24):9457-64. PubMed ID: 19934323
[TBL] [Abstract][Full Text] [Related]
12. Sphingolipids suppress preneoplastic rat hepatocytes in vitro and in vivo.
Silins I; Nordstrand M; Högberg J; Stenius U
Carcinogenesis; 2003 Jun; 24(6):1077-83. PubMed ID: 12807752
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effects of nobiletin and its colonic metabolites on colon carcinogenesis.
Wu X; Song M; Wang M; Zheng J; Gao Z; Xu F; Zhang G; Xiao H
Mol Nutr Food Res; 2015 Dec; 59(12):2383-94. PubMed ID: 26445322
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms.
Lamprecht SA; Lipkin M
Nat Rev Cancer; 2003 Aug; 3(8):601-14. PubMed ID: 12894248
[TBL] [Abstract][Full Text] [Related]
15. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
Nair S; Li W; Kong AN
Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
[TBL] [Abstract][Full Text] [Related]
16. Sphingomyelin in the suppression of colon tumors: prevention versus intervention.
Lemonnier LA; Dillehay DL; Vespremi MJ; Abrams J; Brody E; Schmelz EM
Arch Biochem Biophys; 2003 Nov; 419(2):129-38. PubMed ID: 14592456
[TBL] [Abstract][Full Text] [Related]
17. cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment.
Browning DD; Kwon IK; Wang R
Future Med Chem; 2010 Jan; 2(1):65-80. PubMed ID: 21426046
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds.
Pan MH; Lai CS; Wu JC; Ho CT
Mol Nutr Food Res; 2011 Jan; 55(1):32-45. PubMed ID: 21207511
[TBL] [Abstract][Full Text] [Related]
19. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
20. Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets.
Merrill AH; Schmelz EM; Wang E; Dillehay DL; Rice LG; Meredith F; Riley RT
J Nutr; 1997 May; 127(5 Suppl):830S-833S. PubMed ID: 9164247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
